These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 8988452)
1. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. Maes M; Vandoolaeghe E; Desnyder R J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452 [TBL] [Abstract][Full Text] [Related]
2. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986 [TBL] [Abstract][Full Text] [Related]
3. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Van Hunsel F; Wauters A; Vandoolaeghe E; Neels H; Demedts P; Maes M Psychiatry Res; 1996 Dec; 65(3):159-69. PubMed ID: 9029664 [TBL] [Abstract][Full Text] [Related]
4. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693 [TBL] [Abstract][Full Text] [Related]
5. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920 [TBL] [Abstract][Full Text] [Related]
6. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044 [TBL] [Abstract][Full Text] [Related]
7. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562 [TBL] [Abstract][Full Text] [Related]
9. [Interest of the use of pindolol in the treatment of depression: review]. Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835 [TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus trazodone in the treatment of outpatients with major depression. Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668 [TBL] [Abstract][Full Text] [Related]
12. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. Sacristán JA; Gilaberte I; Boto B; Buesching DP; Obenchain RL; Demitrack M; Pérez Sola V; Alvarez E; Artigas F Int Clin Psychopharmacol; 2000 Mar; 15(2):107-13. PubMed ID: 10759342 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594 [TBL] [Abstract][Full Text] [Related]
15. Pindolol augmentation enhances response outcomes in first depressive episodes. Portella MJ; de Diego-Adeliño J; Puigdemont D; Pérez-Egea R; Alvarez E; Artigas F; Pérez V Eur Neuropsychopharmacol; 2009 Jul; 19(7):516-9. PubMed ID: 19419845 [TBL] [Abstract][Full Text] [Related]
16. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Berman RM; Darnell AM; Miller HL; Anand A; Charney DS Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956 [TBL] [Abstract][Full Text] [Related]
17. How long should pindolol be associated with paroxetine to improve the antidepressant response? Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806 [TBL] [Abstract][Full Text] [Related]
18. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Munizza C; Olivieri L; Di Loreto G; Dionisio P Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574 [TBL] [Abstract][Full Text] [Related]
19. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Isaac MT; Isaac MB; Gallo F; Tournoux A Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018 [TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study. Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]